Sees FY25 adjusted EBITDA $410M-$425M. Sees FY25 CapEx $80M-$90M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CON:
- CON Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Select Medical price target lowered to $23 from $47 at RBC Capital
- Benchmark upgrades Select Medical, sees attractive entry point after pullback
- Concentra Expands with Nova Medical Acquisition
- Concentra price target raised to $25 from $24 at BofA